bf/NASDAQ:MCRB_icon.jpeg

NASDAQ:MCRB

Seres Therapeutics, Inc.

  • Stock

USD

Last Close

0.79

30/08 20:00

Market Cap

149.43M

Beta: 2.63

Volume Today

1.24M

Avg: 2.50M

PE Ratio

−0.98

PFCF: −1.06

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Dec '13
Dec '14
Dec '15
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
Dec '23
revenue
21.77M
-
32.10M
47.48%
28.27M
11.94%
34.51M
22.07%
33.22M
3.74%
144.93M
336.33%
7.13M
95.08%
126.33M
1,672.24%
cost of revenue
80.14M
-
90.57M
13.01%
1.73M
98.09%
1.00M
42.03%
15.11M
1,405.38%
gross profit
21.77M
-
32.10M
47.48%
28.27M
11.94%
-45.64M
261.45%
-57.35M
25.68%
143.19M
349.66%
6.12M
95.72%
111.21M
1,715.99%
selling and marketing expenses
general and administrative expenses
1.25M
-
4.36M
249.96%
16.76M
284.07%
32.62M
94.59%
34.04M
4.37%
32.60M
4.24%
24.75M
24.08%
30.77M
24.35%
69.26M
125.06%
79.69M
15.06%
87.74M
10.10%
selling general and administrative expenses
1.25M
-
4.36M
249.96%
16.76M
284.07%
32.62M
94.59%
34.04M
4.37%
32.60M
4.24%
24.75M
24.08%
30.77M
24.35%
69.26M
125.06%
79.69M
15.06%
87.74M
10.10%
research and development expenses
4.80M
-
10.72M
123.06%
38.09M
255.43%
81.99M
115.22%
89.45M
9.11%
95.95M
7.27%
80.14M
16.48%
90.57M
13.01%
141.89M
56.66%
172.92M
21.87%
145.86M
15.65%
other expenses
425K
-
170K
60%
1.07M
527.06%
981K
7.97%
-1.73M
276.55%
1.00M
157.97%
15.11M
1,405.38%
cost and expenses
6.05M
-
15.08M
149.21%
54.86M
263.72%
114.61M
108.92%
123.50M
7.76%
128.55M
4.09%
104.89M
18.41%
121.34M
15.69%
209.42M
72.58%
253.62M
21.10%
233.60M
7.89%
operating expenses
6.05M
-
15.08M
149.21%
54.86M
263.72%
114.61M
108.92%
123.50M
7.76%
128.55M
4.09%
104.89M
18.41%
121.34M
15.69%
209.42M
72.58%
253.62M
21.10%
218.49M
13.85%
interest expense
42K
-
555K
-
969K
74.59%
1.59M
64.09%
1.17M
26.29%
502K
57.17%
2.92M
482.47%
2.91M
0.48%
6.02M
106.87%
13.18M
118.87%
ebitda
-5.96M
-
-13.47M
125.92%
-54.85M
307.07%
-86.41M
57.53%
-84.14M
2.63%
-100.28M
19.19%
-68.28M
31.91%
-86.20M
26.24%
-62.67M
27.30%
-244.14M
289.57%
-92.17M
62.25%
operating income
-6.05M
-
-15.08M
149.21%
-54.86M
263.72%
-92.84M
69.24%
-91.39M
1.56%
-100.28M
9.73%
-71.88M
28.33%
-88.13M
22.61%
-64.49M
26.82%
-246.49M
282.20%
-107.28M
56.48%
depreciation and amortization
88K
-
190K
115.91%
728K
283.16%
4.21M
477.61%
7.26M
72.63%
7.86M
8.31%
3.59M
54.32%
1.93M
46.34%
1.82M
5.29%
2.35M
28.93%
15.11M
542.33%
total other income expenses net
-8K
-
-1.42M
17,625%
-7K
99.51%
1.26M
18,100%
425K
66.27%
170K
60%
1.60M
839.41%
-997K
162.43%
-1.08M
8.83%
-3.67M
237.97%
-6.45M
75.76%
income before tax
-6.10M
-
-16.71M
173.83%
-54.78M
227.85%
-91.58M
67.18%
-89.38M
2.40%
-98.94M
10.70%
-70.28M
28.97%
-89.13M
26.82%
-65.58M
26.42%
-250.16M
281.46%
-113.72M
54.54%
income tax expense
42K
-
1.63M
3,773.81%
-804K
149.42%
2.23M
377.24%
-1.59M
171.33%
1.34M
184.40%
-6.04M
549.70%
-2.67M
55.71%
-4.08M
52.71%
3.67M
189.83%
net income
-6.10M
-
-16.71M
173.83%
-54.78M
227.85%
-91.58M
67.18%
-89.38M
2.40%
-98.94M
10.70%
-64.24M
35.07%
-86.45M
34.57%
-61.50M
28.87%
-253.82M
312.75%
-113.72M
55.20%
weighted average shs out
29.78M
-
29.78M
0%
23.53M
20.98%
39.85M
69.33%
40.45M
1.51%
40.74M
0.73%
56.65M
39.04%
79.79M
40.85%
91.70M
14.93%
108.08M
17.86%
128.00M
18.44%
weighted average shs out dil
29.78M
-
29.78M
0%
23.53M
20.98%
39.85M
69.33%
40.45M
1.51%
40.74M
0.73%
56.65M
39.04%
79.79M
40.85%
91.70M
14.93%
108.08M
17.86%
128.00M
18.44%
eps
-0.20
-
-0.56
180%
-2.33
316.07%
-2.30
1.29%
-2.21
3.91%
-2.43
9.95%
-1.13
53.50%
-1.08
4.42%
-0.67
37.96%
-2.35
250.75%
-0.89
62.13%
epsdiluted
-0.20
-
-0.56
180%
-2.33
316.07%
-2.30
1.29%
-2.21
3.91%
-2.43
9.95%
-1.13
53.50%
-1.08
4.42%
-0.67
37.96%
-2.35
250.75%
-0.89
62.13%

All numbers in USD (except ratios and percentages)